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Not Your Average Joe
Different people respond differently to pharmaceuticals and envi-
ronmental and occupational chemicals. Some people are sensitive
to the adverse side effects from pharmaceuticals, while most have
no reaction. Some people get lung cancer from cigarette smoking
and others don't. Diethylstilbestrol exposure of fetuses in utero
resulted in the development ofcancer later in life, although equiva-
lent exposures in adults does not cause a detectable increase in can-
cer. This list could go on and on, but the point is that we are
beginning to recognize and understand some ofthe molecular and
biological determinants of susceptibility to chemically mediated
disease and the role that individual differences play. Unfortunately,
regulatory policy has not kept pace with research advances.
Risk estimates are usually based on predicted effects in 70-
kilogram young-adult males. To account for interindividual differ-
ences in response, a 10-fold safety factor is often applied to a given
risk estimate. This safety factor is likely to be high for some chemi-
cals and probably much too low for others. All parties engaged in
science policy have stated a need to identify sensitive subpopula-
tions so that regulations can be based on a more realistic range of
expected risks. A number of issues need to be addressed regarding
sensitive subpopulations, including genetic differences that predis-
pose an individual to risk, gender, age, diet, preexisting disease
conditions, and exposure to mixtures ofchemicals.
Research in the area of genetic susceptibility includes differ-
ences in drug metabolism, DNA repair capabilities, and inherited
mutations in critical target genes. Numerous reports in the scientif-
ic literature have established the presence of polymorphisms in
drug-metabolizing enzymes such as the cytochrome P450
isozymes, glutathione transferase, and N-acetyltransferase.
Polymorphisms in these metabolizing enzymes exert a profound
effect on the rate ofactivation or detoxification oftoxic chemicals
such as benzene, polycyclic aromatic hydrocarbons, and aryl-
amines. For example, a recent study by Douglas Bell and Jack
Taylor ofthe NIEHS have shown that a polymorphism (gene dele-
tion) in a glutathione transferase isozyme significantly increases the
risk ofbladder cancer from cigarette smoking and may account for
25% ofall bladder cancers worldwide.
Genetic differences in DNA repair capacity are emerging as a
key determinant in some environmental diseases. As we learn more
about the genes that control DNA repair rates and specificity, we
undoubtedly will uncover many polymorphisms in DNA repair
pathways that could increase or decrease risk.
Recent characterizations of the breast cancer and colon cancer
susceptibility genes have shown that a mutation in a critical target
gene may drastically increase cancer risk. For example, 85% ofthe
women who harbor the BRCA1 (breast cancer 1) gene will develop
the disease. Once the function of susceptibility genes is known,
effective molecular blocks could possibly be designed to prevent
the development of cancers caused by their expression. Further
study ofinteractions between susceptibility genes and environmen-
tal chemicals is crucial. We also need to further our understanding
of ethnic differences that predispose to risk. Recent discoveries of
polymorphisms in drug-metabolizing enzymes specific to
African-Americans may be related to differences in environmental-
ly related cancers such as lung and bladder cancers.
The most compelling issue in distribution ofrisk is age-depen-
dent differences. Fetuses and children are not just small adults;
their differentiating and developing systems may be especially sensi-
tive to toxic insult. Some effects caused by newborn or in uteroexpo-
sure to chemicals such as PCB-induced behavioral disturbances may
not be manifested until much later in life. This issue is of special
concern in the case ofenvironmental chemicals that mimic or block
the actions ofnaturally occuring hormones that are essential for nor-
mal development. One route ofexposure to such chemicals may be
through breast milk. It is estimated that infants can be exposed to
approximately 50-80 picograms per kilogram body weight per day
of dioxinlike compounds in breast milk from women exposed to
only 4 picograms per kilogram per day of these compounds. This
does not recommend against breastfeeding, though, because of its
many benefits, but it demonstrates that infants may receive much
higher doses of some chemicals compared to adults, at a time in
their life when they are most sensitive.
Women's health issues, inadequately addressed until recently,
have raised our consciousness ofgender and hormonal influences on
susceptibility to disease. There are numerous diseases ofconcern for
women, with breast cancer and endometriosis as two of the most
devastating examples. There is growing evidence ofan environmen-
tal component of these diseases, yet the mechanisms responsible
remain unknown.
Diet exerts a dramatic influence on environmental causes ofdis-
ease. The food we eat changes the way we metabolize chemicals, the
pattern of mutations in selected genes, and the capacity of our
immune systems to combat disease. Clearly, diet is in part responsi-
ble for differences in breast cancer rates observed between Japan and
the United States. Also, changes in diet affect the results of animal
bioassays for cancer. For example, a recent National Toxicology
Program study showed that several chemicals which increased cancer
rates in animals fed adlibitum had no detectable effect when animals
were subjected to diet restriction.
Preexisting diseases and accompanying changes in physiology and
biochemistry mustcertainlychange thewayhumans respond to chemi-
cals. Little is known about the impact ofcommon diseases on sensitive
subpopulations, so this issue remains a priority research question.
Regulatory agencies need to begin developing strategies to evaluate
chemical risks underchronic disease conditions.
We are exposed to a sea of chemicals in day-to-day living. The
interactions ofthese chemicals at the molecular and biological levels
maylead to antagonism, potentiation, or synergism. How to develop
scientifically sound yet economically practical risk assessment strate-
gies for mixtures is one of the most challenging problems con-
fronting regulatory agencies.
Proponents ofenvironmental justice have raised numerous issues
concerning the inequities ofchemical exposure. Clearly, where a per-
son lives will determine the pattern and magnitude ofchemical con-
taminants in his or her body. Strategies need to be developed to
understand the consequences of these exposures and their relation-
ship to the identification ofsensitive subpopulations.
I strongly encourage attempts to identify subpopulations who are
especially sensitive to the adverse health consequences of chemical
exposure. What must follow is the use ofthis information by regu-
latory agencies in making decisions that consider all ofthe social and
scientific factors involved while protecting against the range of
expected risks based on the growing scientific knowledge of the
mechanisms and situations responsible for the distribution ofrisk.
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